Skin cancer is the most common cancer. 1 out of 5 people will experience skin cancer in their life. Early detection allows to save almost all patients, but if it is detected late, therapy costs will be very high, and 1 out of 2 patients will die. Self-examination by patients can play a crucial role in early detection, but without a trustworthy tool, it is not easy and efficient. Patients need support for easy and quick self-check of skin lesions.
The founder Sepehr Beheshti with +6y of experience in data science, getting an MSc degree in AI from USI. Our solution is an AI system able to recognize types of skin lesions by analyzing skin image and patient data with the accuracy equivalent to a +10y experienced dermatologist. Our 1st Market size is CHF 1.3B in the EU and CHF 3.9B worldwide.
